Global Quality Assurance Model for Radiation Therapy Market Growth (Status and Outlook) 2025-2031
The global Quality Assurance Model for Radiation Therapy market size is predicted to grow from US$ 28.5 million in 2025 to US$ 37.3 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.
The Quality Assurance Model for Radiation Therapy helps radiation physicists verify beam alignment, treatment planning systems, dose alignment, and patient positioning, and it also provides a graphical representation of dose volumes. Advanced models enable the creation of 3D tumor representations and patient anatomy, and perform patient-specific quality checks on respiratory-gated radiation therapy sessions.
Rising prevalence of malignancies and colon cancer, patients' pursuit of advanced cancer therapies are the key factors driving the increase in radiotherapy quality assurance models market revenue.
Segmentation by Type
- Low Dose Radiation
- High Dose Radiation
Segmentation by Application
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Head And Neck Cancer
- Skin Cancer
- Others
Market by Region
- Americas
- APAC
- Europe
- Middle East & Africa
Company's Coverage
- Fluke Biomedical
- IBA Dosimetry
- Modus Medical Devices
- PTW Freiburg GmbH
- Standard Imaging
- Sun Nuclear Corporation
- The Phantom Laboratory
- Gammex
- Gold Standard Phantoms
- Shanghai Radiation Therapy Quality Control Center
Key Questions Addressed in this Report
Frequently Asked Questions
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market